https://pubmed.ncbi.nlm.nih.gov/31697824/
Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell...
Antigen-escape relapse has emerged as a major challenge for long-term disease control after CD19-directed therapies, to which dual-targeting of CD19 and CD22...